Knights of Columbus Asset Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9M Buy
102,384
+12,790
+14% +$852K 0.35% 76
2026
Q1
$5.63M Buy
+89,594
New +$6.24M 0.32% 84
2024
Q4
Sell
-10,468
Closed -$702K 393
2024
Q3
$702K Sell
10,468
-8,589
-45% -$705K 0.05% 254
2024
Q2
$2.16M Buy
19,057
+8,330
+78% +$1.05M 0.14% 206
2024
Q1
$1.49M Buy
10,727
+320
+3% +$40.2K 0.11% 225
2023
Q4
$1.29M Buy
10,407
+310
+3% +$31.7K 0.08% 251
2023
Q3
$942K Buy
10,097
+1,276
+14% +$144K 0.09% 240
2023
Q2
$1.13M Buy
8,821
+1,149
+15% +$139K 0.1% 238
2023
Q1
$891K Buy
+7,672
New +$859K 0.09% 239

Other funds holding DXCM

Knights of Columbus Asset Advisors's DXCM Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its DexCom (DXCM) stake by 14% in Q2 2026, buying an estimated $852K and bringing the position to 102,384 shares worth $6.9M. The position accounts for 0.35% of the portfolio, ranked #76.

Knights of Columbus Asset Advisors first reported a position in DXCM in Q1 2023 and has held it in 9 quarters since. 455 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Knights of Columbus Asset Advisors held 102,384 shares of DexCom worth $6.9M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 12,790 DexCom shares in Q2 2026, an estimated $852K.
  • DexCom made up 0.35% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #76 holding.
  • Knights of Columbus Asset Advisors first reported a position in DexCom in Q1 2023 and has held it in 9 quarters since.
  • 455 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.